Economic evaluation of the organizational impact of adopting different in situ hybridization technologies to assess HER2 gene amplification in breast cancer

by Roberto Ravasio, Davide Paolini, Matteo Dionisi, Vincenzo Arena
Published 2017-07-01

Title not available

by Roberto Ravasio, Davide Paolini, Matteo Dionisi, Vincenzo Arena
Published 2017-06-01

Cost-Consequence Analysis of Three Different Diagnostic Strategies in the First- and Second-Line Treatment of Locally Advanced or Metastatic Non-Small-Cell Lung Cancer

by Giovanni Gancitano, Roberto Ravasio, Matteo Dionisi, Diego Cortinovis
Published 2018-05-01

The contingent use of cell-free fetal DNA for prenatal screening of trisomies 21, 18, 13 in pregnant women within a national health service: A budget impact analysis.

by Federico Prefumo, Davide Paolini, Giulia Speranza, Marilena Palmisano, Matteo Dionisi, Lamberto Camurri
Published 2019-01-01

Personalized medicine: biomarkers and companion diagnostics

by Renato Bernardini, Giovanni Gancitano, Angela Balice, Rosaria Di Mauro, Giuseppina Cantarella, Matteo Dionisi
Published 2018-03-01

Title not available

by Alessio Aghemo, Giovanna Lunghi, Roberto Ravasio, Erminio Torresani, Matteo Dionisi, Davide Paolini, Massimo Colombo
Published 2016-01-01

Title not available

by Fiorenzo Massimo Corti, Contardo Luigi Corbetta, Maria P. Consuelo Lampreda, Giovanni Gancitano, Matteo Dionisi
Published 2017-03-01

Cost analysis of residual viremia detected by two real-time PCR assays for response-guided (dual or triple) therapy of HCV genotype 1 infection

by Alessio Aghemo, Giovanna Lunghi, Roberto Ravasio, Erminio Torresani, Matteo Dionisi, Davide Paolini, Massimo Colombo
Published 2016-12-01

Outpatient management of oral anticoagulation treatment (OAT) in general practice: the “Medicina di Gruppo di Masate” experience

by Fiorenzo Massimo Corti, Contardo Luigi Corbetta, Maria P. Consuelo Lampreda, Giovanni Gancitano, Matteo Dionisi
Published 2017-04-01